Donald Trump speeches. Celebrity tweets. Corporate news repetition. Chaos. Vapidity. Manufactured dissent. Graphic fighting sports. This is what fills our field of vision. It consumes our thoughts, overflows our brains with anti-intellectual mud. Yet most of these things are the bug splatter across the windshield. They are not the actual highway, the path forward, actually deserving of our focus. Looking beyond these distractions, one can see what really matters. The true stuff of life and death and oppression and justice.
Jeanne Hochhalter has had health problems since she was a teenager. First came the respiratory issues, then the gastrointestinal and endocrine troubles. But the heaviest blow came in 2013 when a doctor diagnosed her with breast cancer. Since then she’s endured 16 surgeries, as well as chemotherapy. Hochhalter, a 52-year-old real estate agent who grew up in Burr Ridge, Illinois, 25 miles west of Chicago, is now in remission. She couldn’t chalk her cancer up to anything in particular until her mom returned from a town hall meeting in August 2018 with a pamphlet. It detailed the health problems associated with exposure to ethylene oxide, a chemical used to sterilize medical equipment. And a plant doing just that was located fewer than 5 miles away.
The U.S. Environmental Protection Agency (EPA) has continued its glyphosate cover-up by announcing Thursday that they have finished and published their regulatory review and found that glyphosate is ‘not a carcinogen’. In a statement released Thursday the agency said; “EPA has concluded that there are no risks of concern to human health when glyphosate is used according to the label and that it is not a carcinogen.”
Anticipation is building around the belief that there could soon be an announcement of at least a partial settlement of U.S. lawsuits pitting thousands of U.S. cancer patients against Monsanto Co. over allegations the company hid the health risks of its Roundup herbicides. Investors in Bayer AG, the German company that bought Monsanto in 2018, are keeping a close eye on the status of three trials currently still on the docket to get underway this month.
After several months out of the headlines, lawyers for both sides of the nationwide Roundup cancer litigation are gearing up for overlapping trials in the new year as several more cancer patients seek to blame Monsanto for their diseases. Six trials are currently set to take place starting in January, with one in February, two in March and additional trials scheduled almost every month from April through October 2021. Thousands of additional plaintiffs still are working to get trial dates set for their claims.
A newly published study adds to the ever-growing pile of evidence in support of the cancer-causing potential of the weedkiller active ingredient glyphosate. Glyphosate herbicides like Roundup are used on over 85% of genetically modified crops. The new study shows that a very low concentration of glyphosate (in the parts per trillion range and thus environmentally relevant for everyone) can trigger breast cancer when combined with another risk factor. In the study, scientists exposed noncancerous human breast cells to glyphosate in vitro over a course of 21 days.
The nearly 18,000 cancer victims suing Monsanto in the U.S. aren’t alone. Farmers worldwide are taking to the courts to hold Monsanto and its parent company, Bayer, accountable for concealing the truth about the potential dangers associated with its flagship weedkiller, Roundup. The Australian version of the popular news program, “60 Minutes,” earlier this month ran a segment about Michael Ogolirolo, an Australian landscaper who says exposure to Roundup caused his leukemia.
The company also argues that the $2 billion verdict was “unsupported, excessive and unconstitutional.” Monsanto is fighting back against the $2 billion verdict awarded to a couple that claimed the company’s infamous herbicide, Roundup, caused their cancer. Claiming that the plaintiffs’ counsel misconduct was “egregious and rampant,” the mega-corporation is calling for a new trial or judgment notwithstanding verdict. Alva and Alberta Pilliod, a couple in their 70s, used Roundup for 30 years until 2016 when they stopped after being made aware the glyphosate was possibly linked to cancer.
We the undersigned are qualified medical doctors. We are united by our distress at the world’s minimal response to looming environmental disaster, ignoring the early signs of a malignant process. We sympathise with current widespread protest, notably by children who will be the most affected. Peaceful protest can change society. We urge government and media to respond immediately and proportionately.
Money may not be able to buy the purest love, but it can buy the best, life-ending cancer. For Monsanto, giant of rule and misrule in matters of genetically modified crops, known for bullying practices towards farmers, things have not been so rosy of late. Ever the self-promoter of saving the world an agricultural headache (biotech crops being the earth’s touted nutritional salvation), the company has run into a set of legal snags that have raided its funds and risk sinking it, along with Bayer AG, the company that bought it last year for $63 billion.
Monsanto has been ordered to pay some $80 million to an American retiree who blames his cancer on the agribusiness giant's weedkiller Roundup, in a case that could influence the outcome of thousands more like it. A San Francisco jury Wednesday found the firm, which is owned by Bayer, had been "negligent by not using reasonable care" to warn of the risks of its product, ordering it to pay Edwin Hardeman $75 million in punitive damages, a little over $5 million in compensation and $200,000 for medical expenses.
EWG: Verdict In Roundup Trial Latest Blow To Bayer-Monsanto’s Claims Glyphosate Doesn’t Cause Cancer
SAN FRANCISCO – Today’s verdict in favor of a California man who said his cancer was caused by exposure to Bayer AG’s Roundup weedkiller is further evidence that glyphosate, the herbicide’s active ingredient, is carcinogenic to humans, said Environmental Working Group President Ken Cook. In the first phase of Edward Hardeman v. Monsanto Company, the jury sided with arguments and scientific evidence presented by the attorneys for Edward Hardeman that glyphosate was the cause of his non-Hodgkin lymphoma.
There are about 8,700 lawsuits pending against Monsanto, by people who allege that exposure to Roundup weedkiller is responsible for their cancer. Most of the people behind these lawsuits have stories not unlike the one told by Dewayne Johnson, during his landmark jury trial which resulted in a unanimous decision against Monsanto. Like Johnson, many of these people have non-Hodgkin lymphoma—or they have family members who have already died from the disease. They face long, grueling trials as they go up against the biotech behemoth. To Werner Baumann, CEO of Bayer ( acquired Monsanto last year for $63 billion), these people are just “nuisances.”
According to a groundbreaking study published this week in JAMA Internal Medicine, an American Medical Association journal, eating organic foods that are free from pesticides is strongly correlated with a dramatic reduction in the risk of cancer. For the study, a team of French scientists, led by epidemiologist Julia Baudry, tracked the diets of 68,946 French adults, more than three-quarters of which were women. The participants, all volunteers, were then categorized into four groups depending on how often they reported eating 16 organic products, including fruits and vegetables, meat and fish, ready-to-eat meals, vegetable oils and condiments, dietary supplements and other products.
The Department of Health and Human Services is diverting millions of dollars in funding from a number of programs, including the Centers for Disease Control and Prevention and the National Institutes of Health, to pay for housing for the growing population of detained immigrant children. In a letter sent to Sen. Patty Murray, D.-Wash., and obtained by Yahoo News, HHS Secretary Alex Azar outlined his plan to reallocate up to $266 million in funding for the current fiscal year, which ends on Sept. 30, to the Unaccompanied Alien Children (UAC) program in the Office of Refugee Resettlement (ORR). Nearly $80 million of that money will come from other refugee support programs within ORR, which have seen their needs significantly diminished as the Trump administration makes drastic cuts to the annual refugee numbers.